These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38924379)

  • 41. [Gout management: an update].
    Ankli B; Krähenbühl S
    Ther Umsch; 2016; 73(3):115-24. PubMed ID: 27008442
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative Risk of Gout Flares When Initiating or Escalating Various Urate-Lowering Therapy: A Systematic Review With Network Meta-Analysis.
    Maher D; Reeve E; Hopkins A; Tan JM; Tantiongco M; Ailabouni N; Woodman R; Stamp L; Bursill D; Proudman S; Wiese M
    Arthritis Care Res (Hoboken); 2024 Jun; 76(6):871-881. PubMed ID: 38303574
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Using serum urate levels to determine the period free of gouty symptoms after withdrawal of long-term urate-lowering therapy: a prospective study.
    Perez-Ruiz F; Atxotegi J; Hernando I; Calabozo M; Nolla JM
    Arthritis Rheum; 2006 Oct; 55(5):786-90. PubMed ID: 17013833
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Measuring quality of gout management in residential aged care facilities.
    Nguyen AD; Lind KE; Day RO; Ross D; Raban MZ; Georgiou A; Westbrook JI
    Rheumatol Adv Pract; 2022; 6(3):rkac091. PubMed ID: 36465481
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 2020 American College of Rheumatology Guideline for the Management of Gout.
    FitzGerald JD; Dalbeth N; Mikuls T; Brignardello-Petersen R; Guyatt G; Abeles AM; Gelber AC; Harrold LR; Khanna D; King C; Levy G; Libbey C; Mount D; Pillinger MH; Rosenthal A; Singh JA; Sims JE; Smith BJ; Wenger NS; Bae SS; Danve A; Khanna PP; Kim SC; Lenert A; Poon S; Qasim A; Sehra ST; Sharma TSK; Toprover M; Turgunbaev M; Zeng L; Zhang MA; Turner AS; Neogi T
    Arthritis Care Res (Hoboken); 2020 Jun; 72(6):744-760. PubMed ID: 32391934
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 2020 American College of Rheumatology Guideline for the Management of Gout.
    FitzGerald JD; Dalbeth N; Mikuls T; Brignardello-Petersen R; Guyatt G; Abeles AM; Gelber AC; Harrold LR; Khanna D; King C; Levy G; Libbey C; Mount D; Pillinger MH; Rosenthal A; Singh JA; Sims JE; Smith BJ; Wenger NS; Bae SS; Danve A; Khanna PP; Kim SC; Lenert A; Poon S; Qasim A; Sehra ST; Sharma TSK; Toprover M; Turgunbaev M; Zeng L; Zhang MA; Turner AS; Neogi T
    Arthritis Rheumatol; 2020 Jun; 72(6):879-895. PubMed ID: 32390306
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Urate-lowering Therapy and Chronic Kidney Disease Development in Patients with Gout.
    Yen FS; Wei JC; Chang CL; Yang CC; Hsu CC; Hwu CM
    Int J Med Sci; 2021; 18(12):2599-2606. PubMed ID: 34104091
    [No Abstract]   [Full Text] [Related]  

  • 48. Significance of the initiation time of urate-lowering therapy in gout patients: A retrospective research.
    Feng X; Li Y; Gao W
    Joint Bone Spine; 2015 Dec; 82(6):428-31. PubMed ID: 26456042
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-term persistence and adherence on urate-lowering treatment can be maintained in primary care-5-year follow-up of a proof-of-concept study.
    Abhishek A; Jenkins W; La-Crette J; Fernandes G; Doherty M
    Rheumatology (Oxford); 2017 Apr; 56(4):529-533. PubMed ID: 28082620
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Debates in gout management.
    Abhishek A
    Curr Opin Rheumatol; 2020 Mar; 32(2):134-139. PubMed ID: 31842034
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gout: A Rapid Review of Presentation, Diagnosis and Management.
    Badshah M; Nadeem I; Ahmed I; Naim T; Fanciullo J
    S D Med; 2024 Feb; 77(2):81-86. PubMed ID: 38986162
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ultrasound evaluation in follow-up of urate-lowering therapy in gout: the USEFUL study.
    Ebstein E; Forien M; Norkuviene E; Richette P; Mouterde G; Daien C; Ea HK; Brière C; Lioté F; Petraitis M; Bardin T; Ora J; Dieudé P; Ottaviani S
    Rheumatology (Oxford); 2019 Mar; 58(3):410-417. PubMed ID: 30285127
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Shared decision-making in gout treatment: a national study of rheumatology provider opinion and practice.
    Singh JA; Richards JS; Chang E; Toupin-April K; Barton JL
    Clin Rheumatol; 2021 Feb; 40(2):693-700. PubMed ID: 32997317
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Predicting Response or Non-response to Urate-Lowering Therapy in Patients with Gout.
    Graham GG; Stocker SL; Kannangara DRW; Day RO
    Curr Rheumatol Rep; 2018 Jun; 20(8):47. PubMed ID: 29931553
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treat-to-Target urate-lowering therapy in primary gout patients: A real-world retrospective study at a dedicated gout clinic in China.
    Bai XS; Wang M; Zhao XD; Cui LL; He YW; Wang C; Li XD; Qu XJ; Sun MS; Li CG
    Technol Health Care; 2021; 29(1):121-131. PubMed ID: 32444582
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Optimizing adherence to allopurinol for gout: patients' perspectives.
    Spragg JCJ; Michael TJF; Aslani P; Coleshill MJ; Chan JS; Day RO; Stocker SL
    Br J Clin Pharmacol; 2023 Jul; 89(7):1978-1991. PubMed ID: 36607199
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prophylaxis for acute gout flares after initiation of urate-lowering therapy.
    Latourte A; Bardin T; Richette P
    Rheumatology (Oxford); 2014 Nov; 53(11):1920-6. PubMed ID: 24758886
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of Gout Flares With the Initiation of Treat-to-Target Allopurinol and Febuxostat: A Post-Hoc Analysis of a Randomized Multicenter Trial.
    Barry A; Helget LN; Androsenko M; Wu H; Kramer B; Newcomb JA; Brophy MT; Davis-Karim A; England BR; Ferguson R; Pillinger MH; Neogi T; Palevsky PM; Merriman TR; O'Dell JR; Mikuls TR
    Arthritis Rheumatol; 2024 Oct; 76(10):1552-1559. PubMed ID: 38925627
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cost-effectiveness of sequential urate lowering therapies for the management of gout in Singapore.
    Pruis SL; Jeon YK; Pearce F; Thong BY; Aziz MIA
    J Med Econ; 2020 Aug; 23(8):838-847. PubMed ID: 32301360
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.